Back to results
US 2013/0158048 A1Published application
Formulation Solution Adapted to Prolong Plasma Times of Drugs in Mammals Including Humans
OwnerAida Salatinjants, Robert Salantinjantsinventors
Life of this patent
Estimating the term…
Abstract
In the method of administering rifampicin to a human subject, the improvement wherein a prolongation composition is also administered, said prolongation composition comprising: Pectin 0.94 g Potassium bitartrate 0.48 g Tannic acid 0.8 g L-Tyrosine 0.21 g Riboflavin 2 ml 10% solution of 15% Ethyl Alcohol Hexanoic Acid (Caproic acid) 0.06 ml Ethyl Alcohol 15% Ethyl Alcohol to make 100 ml
Claims1
In the method of administering rifampicin to a human subject, the improvement wherein a prolongation composition is also administered, said prolongation composition comprising:
- Pectin
- 0.94
- g
- Potassium bitartrate
- 0.48
- g
- Tannic acid
- 0.8
- g
- L-Tyrosine
- 0.21
- g
- Riboflavin
- 2 ml 10% solution of 15% Ethyl Alcohol
- Hexanoic Acid (Caproic acid)
- 0.06
- ml
- Ethyl Alcohol
- 15% Ethyl Alcohol to make 100 ml
16 more elements
Dependencies are inferred from the claim text.